HPC
Hobart Private Capital’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-9,734
| Closed | -$366K | – | 152 |
|
|
2020
Q3 | $366K | Sell |
9,734
-11,796
| -55% | -$444K | 0.19% | 109 |
|
|
2020
Q2 | $878K | Sell |
21,530
-10,774
| -33% | -$439K | 0.49% | 47 |
|
|
2020
Q1 | $1.22M | Sell |
32,304
-4,705
| -13% | -$178K | 0.84% | 31 |
|
|
2019
Q4 | $1.74M | Buy |
37,009
+1,982
| +6% | +$93.1K | 1.06% | 27 |
|
|
2019
Q3 | $1.49M | Buy |
35,027
+156
| +0.4% | +$6.66K | 1.02% | 26 |
|
|
2019
Q2 | $1.4M | Sell |
34,871
-1,916
| -5% | -$76.7K | 0.97% | 27 |
|
|
2019
Q1 | $1.54M | Sell |
36,787
-4,611
| -11% | -$193K | 1.17% | 23 |
|
|
2018
Q4 | $1.58M | Buy |
41,398
+4,745
| +13% | +$181K | 1.36% | 21 |
|
|
2018
Q3 | $1.47M | Buy |
36,653
+4,558
| +14% | +$183K | 1.13% | 27 |
|
|
2018
Q2 | $1.29M | Sell |
32,095
-2,244
| -7% | -$90.5K | 1.05% | 31 |
|
|
2018
Q1 | $1.34M | Buy |
34,339
+1,144
| +3% | +$44.7K | 1.18% | 25 |
|
|
2017
Q4 | $1.18M | Buy |
+33,195
| New | +$1.18M | 1.05% | 31 |
|